• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDSII CLR 27IN 3-0 S/A FS-1; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDSII CLR 27IN 3-0 S/A FS-1; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Model Number Z442H
Device Problem Break (1069)
Patient Problems Local Reaction (2035); Not Applicable (3189)
Event Date 10/03/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, weight, bmi at the time of index procedure the diagnosis and indication for the index surgical procedure? in what tissue layer was the suture used? what was the tissue condition pre-op, i.E., normal or thin, calcified, fragile, diseased? what was the tissue condition post-op, i.E., normal or thin, calcified, fragile, diseased? what were the current symptoms following the index surgical procedure? onset date? please clarify and describe what is meant by ¿two ears peel off¿? was medical intervention provided for the report of ¿two ears peel off¿? if yes, please describe.What was the appearance of the suture during reoperation on october 3, 2019? are patient photos available? other relevant patient history/concomitant medications product code and lot # if applicable, will the product be returned, return date, tracking information what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient¿s current status? events reported via mw 2210968-2019-89317.
 
Event Description
It was reported that the patient underwent otoplasty on (b)(6) 2019 and suture was used for plication and attachment of concha.In (b)(6) 2019, two ears got peeled off.The patient was operated again on (b)(6) 2019 and no suture was found except a 3.0 absorbable suture on the right concha.Additional information has been requested.
 
Manufacturer Narrative
Product complaint #: (b)(4).Date sent to the fda: 02/13/2020.Additional information: d10, h6.Additional h3 device evaluation summary: three suture pieces of product code z442h was received for analysis.During the visual inspection of the used suture pieces, body fluids and tissue were noted.The product code z442h is absorbable suture and at the time of the second surgery, the suture was on 103 days of the implantation at this time the suture was found absorbed according to the percentage of the original strength, the pds ii clear device is completely absorbed by 182 days post implantation.The manufacturing records could not be reviewed as the batch number is unknown.According to the sample condition, the cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDSII CLR 27IN 3-0 S/A FS-1
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key9261574
MDR Text Key169023394
Report Number2210968-2019-89318
Device Sequence Number1
Product Code NEW
UDI-Device Identifier10705031060975
UDI-Public10705031060975
Combination Product (y/n)N
PMA/PMN Number
N18331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberZ442H
Device Catalogue NumberZ442H
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/10/2020
Initial Date Manufacturer Received 10/04/2019
Initial Date FDA Received10/31/2019
Supplement Dates Manufacturer Received02/10/2020
Supplement Dates FDA Received02/13/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-